| 0 |
PROPOFOL INFUSION SYNDROME |
634 |
0.8993 |
| 1 |
NEGATIVE PRESSURE PULMONARY OEDEMA |
74 |
0.7551 |
| 2 |
END-TIDAL CO2 INCREASED |
34 |
0.7391 |
| 3 |
TRIGEMINO-CARDIAC REFLEX |
59 |
0.7284 |
| 4 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
621 |
0.6854 |
| 5 |
UNWANTED AWARENESS DURING ANAESTHESIA |
166 |
0.5061 |
| 6 |
NEUROMUSCULAR BLOCK PROLONGED |
174 |
0.4715 |
| 7 |
AIRWAY PEAK PRESSURE INCREASED |
71 |
0.4671 |
| 8 |
MITOCHONDRIAL DNA MUTATION |
39 |
0.4535 |
| 9 |
DELAYED RECOVERY FROM ANAESTHESIA |
416 |
0.4388 |
| 10 |
HYPERTHERMIA MALIGNANT |
625 |
0.4197 |
| 11 |
ANAESTHETIC COMPLICATION PULMONARY |
36 |
0.4045 |
| 12 |
RECURRENCE OF NEUROMUSCULAR BLOCKADE |
66 |
0.3860 |
| 13 |
AIRWAY COMPLICATION OF ANAESTHESIA |
100 |
0.3802 |
| 14 |
NEW ONSET REFRACTORY STATUS EPILEPTICUS |
39 |
0.3545 |
| 15 |
ANAESTHETIC COMPLICATION CARDIAC |
24 |
0.3478 |
| 16 |
MECHANICAL VENTILATION COMPLICATION |
49 |
0.3289 |
| 17 |
POSTOPERATIVE DELIRIUM |
65 |
0.3283 |
| 18 |
MYOGLOBIN URINE PRESENT |
73 |
0.2967 |
| 19 |
TRACHEAL DEVIATION |
24 |
0.2727 |
| 20 |
ALLERGY TEST NEGATIVE |
40 |
0.2564 |
| 21 |
NEUROMUSCULAR BLOCKADE |
57 |
0.2545 |
| 22 |
BURKHOLDERIA TEST POSITIVE |
29 |
0.2339 |
| 23 |
INTRA-ABDOMINAL PRESSURE INCREASED |
36 |
0.2293 |
| 24 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
78 |
0.2053 |
| 25 |
CSF OLIGOCLONAL BAND PRESENT |
25 |
0.1923 |
| 26 |
PROCEDURAL HYPOTENSION |
162 |
0.1904 |
| 27 |
CONFUSION POSTOPERATIVE |
24 |
0.1832 |
| 28 |
PHAEOCHROMOCYTOMA CRISIS |
33 |
0.1557 |
| 29 |
MYOCARDIAL DEPRESSION |
39 |
0.1512 |
| 30 |
PHRENIC NERVE PARALYSIS |
31 |
0.1416 |
| 31 |
NECROSIS ISCHAEMIC |
60 |
0.1302 |
| 32 |
ANAESTHETIC COMPLICATION |
348 |
0.1295 |
| 33 |
ANAPHYLACTOID SHOCK |
57 |
0.1213 |
| 34 |
HEPATIC ISCHAEMIA |
36 |
0.1158 |
| 35 |
PCO2 INCREASED |
82 |
0.1152 |
| 36 |
CARCINOID CRISIS |
25 |
0.1106 |
| 37 |
TRYPTASE INCREASED |
74 |
0.1036 |
| 38 |
SPINAL MUSCULAR ATROPHY |
27 |
0.1000 |
| 39 |
MATERNAL EXPOSURE DURING DELIVERY |
99 |
0.0999 |
| 40 |
MEAN ARTERIAL PRESSURE DECREASED |
24 |
0.0949 |
| 41 |
OPERATIVE HAEMORRHAGE |
42 |
0.0940 |
| 42 |
INSPIRATORY CAPACITY DECREASED |
26 |
0.0939 |
| 43 |
DIABETES INSIPIDUS |
226 |
0.0938 |
| 44 |
POSTOPERATIVE FEVER |
26 |
0.0929 |
| 45 |
ANAPHYLACTIC SHOCK |
2289 |
0.0887 |
| 46 |
NEONATAL RESPIRATORY DEPRESSION |
29 |
0.0873 |
| 47 |
ENDOTRACHEAL INTUBATION COMPLICATION |
51 |
0.0864 |
| 48 |
PO2 INCREASED |
41 |
0.0809 |
| 49 |
TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT |
68 |
0.0802 |
| 50 |
BLOOD GASES ABNORMAL |
43 |
0.0798 |
| 51 |
LARYNGOSPASM |
212 |
0.0788 |
| 52 |
PROCEDURAL VOMITING |
51 |
0.0785 |
| 53 |
LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
27 |
0.0776 |
| 54 |
HYPOCAPNIA |
32 |
0.0766 |
| 55 |
ELECTROMECHANICAL DISSOCIATION |
61 |
0.0763 |
| 56 |
RENAL ISCHAEMIA |
41 |
0.0750 |
| 57 |
BRADYCARDIA FOETAL |
60 |
0.0722 |
| 58 |
PNEUMATOSIS |
32 |
0.0717 |
| 59 |
RESPIRATORY ACIDOSIS |
281 |
0.0714 |
| 60 |
PROCEDURAL NAUSEA |
56 |
0.0696 |
| 61 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
227 |
0.0685 |
| 62 |
VASOPLEGIA SYNDROME |
112 |
0.0683 |
| 63 |
HYPERCAPNIA |
205 |
0.0680 |
| 64 |
PRODUCT CONTAMINATION MICROBIAL |
81 |
0.0679 |
| 65 |
BRONCHOSPASM |
953 |
0.0667 |
| 66 |
INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT |
24 |
0.0661 |
| 67 |
MYOGLOBINURIA |
35 |
0.0657 |
| 68 |
UPPER AIRWAY OBSTRUCTION |
58 |
0.0654 |
| 69 |
SKIN TEST POSITIVE |
61 |
0.0654 |
| 70 |
OPISTHOTONUS |
51 |
0.0642 |
| 71 |
LABILE BLOOD PRESSURE |
76 |
0.0640 |
| 72 |
NEPHROGENIC DIABETES INSIPIDUS |
72 |
0.0624 |
| 73 |
DRUG EFFECT PROLONGED |
34 |
0.0616 |
| 74 |
HYPOXIC ENCEPHALOPATHY |
25 |
0.0610 |
| 75 |
ACIDOSIS HYPERCHLORAEMIC |
36 |
0.0606 |
| 76 |
PULSELESS ELECTRICAL ACTIVITY |
252 |
0.0602 |
| 77 |
AIR EMBOLISM |
28 |
0.0594 |
| 78 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
61 |
0.0574 |
| 79 |
MULTIPLE-DRUG RESISTANCE |
178 |
0.0573 |
| 80 |
KOUNIS SYNDROME |
130 |
0.0572 |
| 81 |
BRUGADA SYNDROME |
59 |
0.0570 |
| 82 |
HAEMODYNAMIC INSTABILITY |
422 |
0.0553 |
| 83 |
STATUS EPILEPTICUS |
607 |
0.0537 |
| 84 |
STRESS CARDIOMYOPATHY |
312 |
0.0536 |
| 85 |
NON-CARDIOGENIC PULMONARY OEDEMA |
56 |
0.0529 |
| 86 |
ANTICHOLINERGIC SYNDROME |
83 |
0.0521 |
| 87 |
CONGESTIVE HEPATOPATHY |
23 |
0.0513 |
| 88 |
SINUS ARREST |
80 |
0.0510 |
| 89 |
HYPOVENTILATION |
166 |
0.0509 |
| 90 |
ISCHAEMIC CEREBRAL INFARCTION |
59 |
0.0508 |
| 91 |
RESPIRATORY TRACT INFECTION BACTERIAL |
25 |
0.0502 |
| 92 |
HEPATORENAL FAILURE |
30 |
0.0498 |
| 93 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
109 |
0.0496 |
| 94 |
MACROGLOSSIA |
27 |
0.0491 |
| 95 |
BLOOD PH DECREASED |
81 |
0.0473 |
| 96 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
52 |
0.0473 |
| 97 |
ABDOMINAL COMPARTMENT SYNDROME |
30 |
0.0471 |
| 98 |
SUBCUTANEOUS EMPHYSEMA |
46 |
0.0468 |
| 99 |
CARDIAC OUTPUT DECREASED |
41 |
0.0464 |
| 100 |
PLEOCYTOSIS |
26 |
0.0447 |
| 101 |
APNOEIC ATTACK |
25 |
0.0443 |
| 102 |
PNEUMOCOCCAL SEPSIS |
29 |
0.0441 |
| 103 |
VENTRICULAR FIBRILLATION |
483 |
0.0434 |
| 104 |
SEIZURE LIKE PHENOMENA |
73 |
0.0430 |
| 105 |
DRUG LEVEL CHANGED |
27 |
0.0429 |
| 106 |
RESUSCITATION |
71 |
0.0428 |
| 107 |
CLONUS |
117 |
0.0427 |
| 108 |
ELECTROENCEPHALOGRAM ABNORMAL |
134 |
0.0424 |
| 109 |
ARTERIOSPASM CORONARY |
170 |
0.0423 |
| 110 |
SEROTONIN SYNDROME |
805 |
0.0419 |
| 111 |
FOETAL EXPOSURE DURING DELIVERY |
28 |
0.0413 |
| 112 |
RESPIRATORY DEPRESSION |
500 |
0.0408 |
| 113 |
TONIC CLONIC MOVEMENTS |
52 |
0.0400 |
| 114 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
104 |
0.0397 |
| 115 |
PO2 DECREASED |
45 |
0.0391 |
| 116 |
APNOEA |
302 |
0.0388 |
| 117 |
CLONIC CONVULSION |
28 |
0.0383 |
| 118 |
STRIDOR |
112 |
0.0380 |
| 119 |
SEDATION COMPLICATION |
96 |
0.0376 |
| 120 |
BLOOD PRESSURE IMMEASURABLE |
57 |
0.0372 |
| 121 |
SUSPECTED PRODUCT CONTAMINATION |
36 |
0.0355 |
| 122 |
APGAR SCORE LOW |
44 |
0.0341 |
| 123 |
TORSADE DE POINTES |
268 |
0.0341 |
| 124 |
CIRCULATORY COLLAPSE |
577 |
0.0338 |
| 125 |
ANAPHYLACTIC REACTION |
1849 |
0.0334 |
| 126 |
METHAEMOGLOBINAEMIA |
77 |
0.0332 |
| 127 |
PRINZMETAL ANGINA |
33 |
0.0332 |
| 128 |
INTESTINAL ISCHAEMIA |
182 |
0.0330 |
| 129 |
INTESTINAL PSEUDO-OBSTRUCTION |
29 |
0.0330 |
| 130 |
MYOCLONIC EPILEPSY |
49 |
0.0323 |
| 131 |
PUPILS UNEQUAL |
36 |
0.0314 |
| 132 |
NODAL RHYTHM |
46 |
0.0314 |
| 133 |
HYPERTRIGLYCERIDAEMIA |
184 |
0.0314 |
| 134 |
HEPATORENAL SYNDROME |
53 |
0.0314 |
| 135 |
TYPE I HYPERSENSITIVITY |
110 |
0.0312 |
| 136 |
PERFORATION |
25 |
0.0310 |
| 137 |
BRADYARRHYTHMIA |
51 |
0.0310 |
| 138 |
PROCEDURAL COMPLICATION |
237 |
0.0309 |
| 139 |
VENTRICULAR TACHYCARDIA |
509 |
0.0308 |
| 140 |
MYOCLONUS |
367 |
0.0307 |
| 141 |
BLOOD BICARBONATE DECREASED |
58 |
0.0306 |
| 142 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
25 |
0.0304 |
| 143 |
ENDOTRACHEAL INTUBATION |
85 |
0.0303 |
| 144 |
PULSE ABSENT |
144 |
0.0302 |
| 145 |
PCO2 DECREASED |
29 |
0.0300 |
| 146 |
MULTI-ORGAN FAILURE |
505 |
0.0292 |
| 147 |
HYPERTHERMIA |
223 |
0.0292 |
| 148 |
BRADYCARDIA |
1515 |
0.0285 |
| 149 |
PULMONARY ALVEOLAR HAEMORRHAGE |
158 |
0.0281 |
| 150 |
ANAPHYLACTOID REACTION |
115 |
0.0279 |
| 151 |
ACUTE LUNG INJURY |
33 |
0.0278 |
| 152 |
VENTRICULAR ARRHYTHMIA |
101 |
0.0276 |
| 153 |
BLOOD LACTIC ACID INCREASED |
145 |
0.0275 |
| 154 |
BRAIN HERNIATION |
82 |
0.0274 |
| 155 |
VENTRICULAR HYPOKINESIA |
86 |
0.0267 |
| 156 |
CONTINUOUS HAEMODIAFILTRATION |
26 |
0.0266 |
| 157 |
CARDIAC ARREST |
2191 |
0.0265 |
| 158 |
CARDIOVASCULAR INSUFFICIENCY |
43 |
0.0264 |
| 159 |
GAZE PALSY |
45 |
0.0264 |
| 160 |
ACUTE PULMONARY OEDEMA |
144 |
0.0256 |
| 161 |
MYOGLOBIN BLOOD INCREASED |
39 |
0.0255 |
| 162 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
130 |
0.0253 |
| 163 |
POST PROCEDURAL COMPLICATION |
487 |
0.0253 |
| 164 |
MECHANICAL VENTILATION |
48 |
0.0252 |
| 165 |
MYOCARDIAL INJURY |
28 |
0.0249 |
| 166 |
PUPIL FIXED |
43 |
0.0248 |
| 167 |
RHABDOMYOLYSIS |
1034 |
0.0248 |
| 168 |
PRODUCT CONTAMINATION |
88 |
0.0247 |
| 169 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
72 |
0.0246 |
| 170 |
THYROTOXIC CRISIS |
28 |
0.0246 |
| 171 |
GENERALISED ERYTHEMA |
140 |
0.0246 |
| 172 |
NEUROMYOPATHY |
26 |
0.0244 |
| 173 |
OCULOGYRIC CRISIS |
52 |
0.0242 |
| 174 |
BRAIN DEATH |
74 |
0.0239 |
| 175 |
SYSTOLIC DYSFUNCTION |
25 |
0.0237 |
| 176 |
TACHYARRHYTHMIA |
59 |
0.0236 |
| 177 |
HYPERREFLEXIA |
82 |
0.0235 |
| 178 |
HYPERLACTACIDAEMIA |
63 |
0.0235 |
| 179 |
ATRIOVENTRICULAR BLOCK COMPLETE |
156 |
0.0233 |
| 180 |
CONVERSION DISORDER |
45 |
0.0232 |
| 181 |
PARTIAL SEIZURES |
121 |
0.0231 |
| 182 |
HYPERNATRAEMIA |
115 |
0.0231 |
| 183 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
88 |
0.0230 |
| 184 |
HYPORESPONSIVE TO STIMULI |
27 |
0.0230 |
| 185 |
ACIDOSIS |
175 |
0.0229 |
| 186 |
HYPOPERFUSION |
24 |
0.0228 |
| 187 |
HYPOXIA |
801 |
0.0227 |
| 188 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
69 |
0.0227 |
| 189 |
INCREASED BRONCHIAL SECRETION |
58 |
0.0227 |
| 190 |
ISCHAEMIC HEPATITIS |
31 |
0.0226 |
| 191 |
AREFLEXIA |
60 |
0.0225 |
| 192 |
NEUROLOGICAL DECOMPENSATION |
52 |
0.0225 |
| 193 |
METABOLIC ACIDOSIS |
713 |
0.0223 |
| 194 |
LONG QT SYNDROME |
52 |
0.0217 |
| 195 |
OLIGURIA |
133 |
0.0214 |
| 196 |
AMYLASE INCREASED |
79 |
0.0214 |
| 197 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
165 |
0.0212 |
| 198 |
TOXIC ENCEPHALOPATHY |
107 |
0.0211 |
| 199 |
SHOCK |
484 |
0.0210 |
| 200 |
HEPATITIS FULMINANT |
62 |
0.0209 |
| 201 |
VENTRICULAR DYSFUNCTION |
54 |
0.0208 |
| 202 |
SUPERINFECTION |
31 |
0.0207 |
| 203 |
LOW BIRTH WEIGHT BABY |
164 |
0.0206 |
| 204 |
PUPILLARY REFLEX IMPAIRED |
37 |
0.0200 |
| 205 |
MUTISM |
29 |
0.0200 |
| 206 |
VENTRICULAR EXTRASYSTOLES |
207 |
0.0199 |
| 207 |
HYPOVOLAEMIA |
116 |
0.0198 |
| 208 |
RESPIRATORY ALKALOSIS |
32 |
0.0197 |
| 209 |
BRAIN OEDEMA |
248 |
0.0196 |
| 210 |
LARYNGEAL OEDEMA |
119 |
0.0193 |
| 211 |
QUADRIPARESIS |
32 |
0.0193 |
| 212 |
GENE MUTATION |
38 |
0.0192 |
| 213 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
33 |
0.0190 |
| 214 |
MUSCLE RIGIDITY |
227 |
0.0190 |
| 215 |
TOXIC EPIDERMAL NECROLYSIS |
287 |
0.0189 |
| 216 |
TORTICOLLIS |
40 |
0.0189 |
| 217 |
ATELECTASIS |
182 |
0.0188 |
| 218 |
PNEUMOMEDIASTINUM |
34 |
0.0188 |
| 219 |
ELECTROCARDIOGRAM T WAVE INVERSION |
41 |
0.0185 |
| 220 |
CARBON DIOXIDE INCREASED |
25 |
0.0183 |
| 221 |
TACHYPNOEA |
248 |
0.0182 |
| 222 |
COMPARTMENT SYNDROME |
47 |
0.0180 |
| 223 |
PRIAPISM |
62 |
0.0180 |
| 224 |
POSTPARTUM HAEMORRHAGE |
24 |
0.0178 |
| 225 |
SINUS BRADYCARDIA |
171 |
0.0177 |
| 226 |
SHOCK HAEMORRHAGIC |
144 |
0.0177 |
| 227 |
MIXED LIVER INJURY |
53 |
0.0176 |
| 228 |
EXTRAVASATION |
72 |
0.0175 |
| 229 |
CARDIOGENIC SHOCK |
251 |
0.0175 |
| 230 |
OXYGEN SATURATION DECREASED |
975 |
0.0173 |
| 231 |
NYSTAGMUS |
92 |
0.0173 |
| 232 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
305 |
0.0172 |
| 233 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
25 |
0.0171 |
| 234 |
FEAR |
459 |
0.0170 |
| 235 |
SINUS TACHYCARDIA |
242 |
0.0170 |
| 236 |
OXYGEN SATURATION ABNORMAL |
48 |
0.0169 |
| 237 |
FEAR OF DEATH |
38 |
0.0169 |
| 238 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
478 |
0.0169 |
| 239 |
CYTOLYTIC HEPATITIS |
56 |
0.0169 |
| 240 |
HYPOTENSION |
3377 |
0.0168 |
| 241 |
COAGULOPATHY |
280 |
0.0168 |
| 242 |
BLOOD PRESSURE SYSTOLIC DECREASED |
75 |
0.0165 |
| 243 |
SUSPECTED PRODUCT QUALITY ISSUE |
30 |
0.0164 |
| 244 |
TROPONIN INCREASED |
124 |
0.0163 |
| 245 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
469 |
0.0163 |
| 246 |
SUPRAVENTRICULAR EXTRASYSTOLES |
55 |
0.0163 |
| 247 |
PSEUDOMONAL SEPSIS |
28 |
0.0160 |
| 248 |
SPUTUM INCREASED |
34 |
0.0157 |
| 249 |
GENERALISED TONIC-CLONIC SEIZURE |
260 |
0.0157 |
| 250 |
CHOREA |
27 |
0.0157 |
| 251 |
ATRIOVENTRICULAR BLOCK |
121 |
0.0156 |
| 252 |
TACHYCARDIA |
1381 |
0.0155 |
| 253 |
HEPATOCELLULAR DAMAGE |
35 |
0.0155 |
| 254 |
DISSEMINATED INTRAVASCULAR COAGULATION |
218 |
0.0155 |
| 255 |
HEPATITIS ACUTE |
100 |
0.0154 |
| 256 |
PROCEDURAL HAEMORRHAGE |
60 |
0.0153 |
| 257 |
RESPIRATORY RATE DECREASED |
48 |
0.0153 |
| 258 |
RASH MORBILLIFORM |
42 |
0.0151 |
| 259 |
INTRA-ABDOMINAL HAEMORRHAGE |
36 |
0.0151 |
| 260 |
CHRONIC GASTRITIS |
34 |
0.0150 |
| 261 |
MYDRIASIS |
193 |
0.0150 |
| 262 |
LEFT VENTRICULAR DYSFUNCTION |
100 |
0.0149 |
| 263 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
142 |
0.0149 |
| 264 |
FOETAL DEATH |
77 |
0.0148 |
| 265 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
73 |
0.0148 |
| 266 |
PANCREATITIS NECROTISING |
34 |
0.0148 |
| 267 |
BRONCHIAL DISORDER |
23 |
0.0148 |
| 268 |
NEUROLEPTIC MALIGNANT SYNDROME |
175 |
0.0147 |
| 269 |
PNEUMONIA STAPHYLOCOCCAL |
29 |
0.0147 |
| 270 |
CHEST X-RAY ABNORMAL |
45 |
0.0147 |
| 271 |
PARADOXICAL DRUG REACTION |
54 |
0.0147 |
| 272 |
SUPRAVENTRICULAR TACHYCARDIA |
140 |
0.0146 |
| 273 |
PARAPLEGIA |
42 |
0.0145 |
| 274 |
LEFT VENTRICULAR HYPERTROPHY |
62 |
0.0145 |
| 275 |
HAEMOTHORAX |
42 |
0.0145 |
| 276 |
ACUTE HEPATIC FAILURE |
197 |
0.0144 |
| 277 |
HYPERAMMONAEMIA |
72 |
0.0144 |
| 278 |
LUNG CONSOLIDATION |
40 |
0.0143 |
| 279 |
CYANOSIS |
224 |
0.0142 |
| 280 |
HYPERAEMIA |
28 |
0.0142 |
| 281 |
HYPERKALAEMIA |
495 |
0.0141 |
| 282 |
HAEMODIALYSIS |
117 |
0.0139 |
| 283 |
DYSTONIA |
270 |
0.0139 |
| 284 |
RESPIRATORY ARREST |
382 |
0.0138 |
| 285 |
UNRESPONSIVE TO STIMULI |
357 |
0.0138 |
| 286 |
NEPHROGENIC ANAEMIA |
64 |
0.0138 |
| 287 |
RENAL INJURY |
409 |
0.0138 |
| 288 |
DEAFNESS NEUROSENSORY |
45 |
0.0137 |
| 289 |
HYPOTHERMIA |
135 |
0.0133 |
| 290 |
POLYURIA |
109 |
0.0133 |
| 291 |
COMA SCALE ABNORMAL |
38 |
0.0131 |
| 292 |
ANHEDONIA |
341 |
0.0130 |
| 293 |
ABDOMINAL RIGIDITY |
35 |
0.0129 |
| 294 |
ANURIA |
111 |
0.0129 |
| 295 |
HEPATOCELLULAR INJURY |
182 |
0.0128 |
| 296 |
HEPATIC NECROSIS |
48 |
0.0127 |
| 297 |
QUADRIPLEGIA |
26 |
0.0126 |
| 298 |
ACUTE RESPIRATORY FAILURE |
242 |
0.0126 |
| 299 |
POTENTIATING DRUG INTERACTION |
42 |
0.0125 |
| 300 |
PREMATURE DELIVERY |
198 |
0.0124 |
| 301 |
TRISMUS |
64 |
0.0124 |
| 302 |
ACCIDENTAL DEATH |
23 |
0.0124 |
| 303 |
HYPERPARATHYROIDISM SECONDARY |
31 |
0.0124 |
| 304 |
RENAL FAILURE ACUTE |
524 |
0.0123 |
| 305 |
PREMATURE BABY |
371 |
0.0123 |
| 306 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
316 |
0.0123 |
| 307 |
KLEBSIELLA INFECTION |
62 |
0.0122 |
| 308 |
CEREBRAL ISCHAEMIA |
63 |
0.0122 |
| 309 |
ELECTROCARDIOGRAM QT PROLONGED |
439 |
0.0122 |
| 310 |
NECROTISING FASCIITIS |
43 |
0.0122 |
| 311 |
STUPOR |
39 |
0.0121 |
| 312 |
PERIORBITAL OEDEMA |
63 |
0.0121 |
| 313 |
ENCEPHALOPATHY |
295 |
0.0120 |
| 314 |
HEPATIC CYTOLYSIS |
153 |
0.0120 |
| 315 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
52 |
0.0120 |
| 316 |
RESPIRATORY FAILURE |
870 |
0.0119 |
| 317 |
RENAL TUBULAR NECROSIS |
117 |
0.0119 |
| 318 |
DISTRIBUTIVE SHOCK |
27 |
0.0119 |
| 319 |
CARDIO-RESPIRATORY ARREST |
498 |
0.0119 |
| 320 |
HEPATITIS TOXIC |
31 |
0.0119 |
| 321 |
HYPERTONIA |
68 |
0.0119 |
| 322 |
BRADYPNOEA |
32 |
0.0118 |
| 323 |
PATENT DUCTUS ARTERIOSUS |
47 |
0.0118 |
| 324 |
BUNDLE BRANCH BLOCK LEFT |
50 |
0.0118 |
| 325 |
BRAIN INJURY |
118 |
0.0118 |
| 326 |
THERAPEUTIC AGENT TOXICITY |
39 |
0.0117 |
| 327 |
OBSTRUCTIVE AIRWAYS DISORDER |
130 |
0.0117 |
| 328 |
INTRACRANIAL PRESSURE INCREASED |
65 |
0.0117 |
| 329 |
VASODILATATION |
29 |
0.0115 |
| 330 |
LIVEDO RETICULARIS |
24 |
0.0115 |
| 331 |
HYPOVOLAEMIC SHOCK |
55 |
0.0115 |
| 332 |
BLOOD PRESSURE DECREASED |
760 |
0.0114 |
| 333 |
EXTRASYSTOLES |
79 |
0.0113 |
| 334 |
DRUG INTERACTION |
1793 |
0.0113 |
| 335 |
TONGUE OEDEMA |
43 |
0.0113 |
| 336 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
57 |
0.0112 |
| 337 |
BUNDLE BRANCH BLOCK RIGHT |
51 |
0.0111 |
| 338 |
CATATONIA |
58 |
0.0110 |
| 339 |
GRAND MAL CONVULSION |
99 |
0.0107 |
| 340 |
HYPOTONIA |
107 |
0.0107 |
| 341 |
NORMAL NEWBORN |
58 |
0.0107 |
| 342 |
ESCHERICHIA BACTERAEMIA |
25 |
0.0106 |
| 343 |
MYOCARDIAL ISCHAEMIA |
121 |
0.0106 |
| 344 |
POST PROCEDURAL HAEMORRHAGE |
123 |
0.0106 |
| 345 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
28 |
0.0105 |
| 346 |
HYPERVENTILATION |
61 |
0.0105 |
| 347 |
PULMONARY OEDEMA |
466 |
0.0104 |
| 348 |
HYPOPNOEA |
36 |
0.0104 |
| 349 |
INCORRECT DRUG ADMINISTRATION RATE |
44 |
0.0103 |
| 350 |
CARDIOPULMONARY FAILURE |
40 |
0.0102 |
| 351 |
ASPIRATION |
112 |
0.0102 |
| 352 |
PNEUMOTHORAX |
162 |
0.0102 |
| 353 |
RESPIRATORY DISTRESS |
281 |
0.0102 |
| 354 |
METABOLIC DISORDER |
59 |
0.0101 |
| 355 |
HEPATIC FAILURE |
305 |
0.0101 |
| 356 |
CARDIAC FAILURE ACUTE |
67 |
0.0100 |
| 357 |
SEPTIC SHOCK |
435 |
0.0100 |
| 358 |
THROMBOPHLEBITIS |
35 |
0.0100 |
| 359 |
MUSCLE CONTRACTIONS INVOLUNTARY |
35 |
0.0099 |
| 360 |
HYPERBILIRUBINAEMIA |
103 |
0.0099 |
| 361 |
PRODUCT PACKAGING CONFUSION |
24 |
0.0099 |
| 362 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
390 |
0.0098 |
| 363 |
BILIRUBIN CONJUGATED INCREASED |
23 |
0.0098 |
| 364 |
RASH MACULO-PAPULAR |
218 |
0.0098 |
| 365 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
155 |
0.0098 |
| 366 |
LEUKOCYTOSIS |
176 |
0.0097 |
| 367 |
ORGAN FAILURE |
39 |
0.0097 |
| 368 |
METABOLIC ENCEPHALOPATHY |
29 |
0.0097 |
| 369 |
DELIRIUM |
335 |
0.0096 |
| 370 |
HEPATITIS C |
116 |
0.0096 |
| 371 |
DRUG LEVEL BELOW THERAPEUTIC |
53 |
0.0096 |
| 372 |
PERIPHERAL ISCHAEMIA |
39 |
0.0095 |
| 373 |
ANTINUCLEAR ANTIBODY POSITIVE |
31 |
0.0095 |
| 374 |
DIASTOLIC DYSFUNCTION |
29 |
0.0094 |
| 375 |
URINE OUTPUT DECREASED |
82 |
0.0094 |
| 376 |
EOSINOPHILIA |
162 |
0.0092 |
| 377 |
INJURY |
643 |
0.0091 |
| 378 |
HISTIOCYTOSIS HAEMATOPHAGIC |
27 |
0.0091 |
| 379 |
ELECTROCARDIOGRAM ABNORMAL |
71 |
0.0090 |
| 380 |
ILEUS |
112 |
0.0090 |
| 381 |
HYPERTENSIVE CRISIS |
100 |
0.0090 |
| 382 |
LIP OEDEMA |
38 |
0.0090 |
| 383 |
COMA |
426 |
0.0089 |
| 384 |
WEIGHT BEARING DIFFICULTY |
24 |
0.0089 |
| 385 |
MOTOR DYSFUNCTION |
90 |
0.0088 |
| 386 |
PARALYSIS |
126 |
0.0088 |
| 387 |
BLOOD PHOSPHORUS INCREASED |
24 |
0.0088 |
| 388 |
PNEUMONIA ASPIRATION |
219 |
0.0088 |
| 389 |
HYPERPYREXIA |
37 |
0.0087 |
| 390 |
CHOLESTASIS |
167 |
0.0087 |
| 391 |
CAESAREAN SECTION |
101 |
0.0087 |
| 392 |
FACE OEDEMA |
146 |
0.0086 |
| 393 |
HEPATITIS CHOLESTATIC |
52 |
0.0086 |
| 394 |
RENAL FAILURE |
1129 |
0.0085 |
| 395 |
LACTIC ACIDOSIS |
275 |
0.0085 |
| 396 |
LUNG INFILTRATION |
75 |
0.0085 |
| 397 |
SCOLIOSIS |
52 |
0.0084 |
| 398 |
AGITATION |
615 |
0.0084 |
| 399 |
RENAL IMPAIRMENT |
702 |
0.0083 |
| 400 |
CARDIAC DYSFUNCTION |
31 |
0.0083 |
| 401 |
FOETAL EXPOSURE DURING PREGNANCY |
668 |
0.0082 |
| 402 |
CONGENITAL ANOMALY |
63 |
0.0081 |
| 403 |
HEPATITIS |
207 |
0.0081 |
| 404 |
ENCEPHALITIS |
55 |
0.0079 |
| 405 |
PULMONARY HAEMORRHAGE |
62 |
0.0079 |
| 406 |
RALES |
46 |
0.0079 |
| 407 |
HYPERVOLAEMIA |
39 |
0.0079 |
| 408 |
CONJUNCTIVAL HYPERAEMIA |
28 |
0.0078 |
| 409 |
HYPOALBUMINAEMIA |
61 |
0.0078 |
| 410 |
INTRACARDIAC THROMBUS |
24 |
0.0078 |
| 411 |
PREMATURE LABOUR |
44 |
0.0078 |
| 412 |
HYPERTRANSAMINASAEMIA |
54 |
0.0078 |
| 413 |
DRUG USE DISORDER |
65 |
0.0077 |
| 414 |
NECROSIS |
43 |
0.0077 |
| 415 |
PSEUDOMONAS INFECTION |
66 |
0.0077 |
| 416 |
EMBOLIC STROKE |
27 |
0.0077 |
| 417 |
PANCREATITIS ACUTE |
170 |
0.0076 |
| 418 |
BLOOD ALBUMIN DECREASED |
60 |
0.0076 |
| 419 |
OLIGOHYDRAMNIOS |
25 |
0.0075 |
| 420 |
BLOOD POTASSIUM INCREASED |
121 |
0.0074 |
| 421 |
EYE MOVEMENT DISORDER |
51 |
0.0074 |
| 422 |
CEREBRAL HAEMATOMA |
25 |
0.0074 |
| 423 |
DISEASE COMPLICATION |
34 |
0.0074 |
| 424 |
CARDIOMEGALY |
91 |
0.0074 |
| 425 |
FIBRIN D DIMER INCREASED |
26 |
0.0073 |
| 426 |
ALTERED STATE OF CONSCIOUSNESS |
157 |
0.0072 |
| 427 |
CARDIOTOXICITY |
64 |
0.0072 |
| 428 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
391 |
0.0071 |
| 429 |
ACUTE KIDNEY INJURY |
1089 |
0.0071 |
| 430 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
43 |
0.0071 |
| 431 |
BODY TEMPERATURE INCREASED |
144 |
0.0071 |
| 432 |
PROTHROMBIN TIME PROLONGED |
42 |
0.0070 |
| 433 |
UNEVALUABLE EVENT |
530 |
0.0070 |
| 434 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
45 |
0.0070 |
| 435 |
ILEUS PARALYTIC |
31 |
0.0069 |
| 436 |
BLOOD CALCIUM DECREASED |
78 |
0.0069 |
| 437 |
STEVENS-JOHNSON SYNDROME |
154 |
0.0069 |
| 438 |
TRICUSPID VALVE INCOMPETENCE |
55 |
0.0069 |
| 439 |
ALANINE AMINOTRANSFERASE INCREASED |
425 |
0.0069 |
| 440 |
BLOOD BILIRUBIN INCREASED |
185 |
0.0068 |
| 441 |
DYSKINESIA |
278 |
0.0068 |
| 442 |
NO THERAPEUTIC RESPONSE |
83 |
0.0068 |
| 443 |
ANGIOEDEMA |
299 |
0.0068 |
| 444 |
MONOPLEGIA |
29 |
0.0067 |
| 445 |
DERMATITIS BULLOUS |
48 |
0.0066 |
| 446 |
DRUG TOXICITY |
90 |
0.0066 |
| 447 |
COVID-19 PNEUMONIA |
78 |
0.0066 |
| 448 |
RESPIRATORY RATE INCREASED |
58 |
0.0065 |
| 449 |
SALIVARY HYPERSECRETION |
65 |
0.0065 |
| 450 |
ASPARTATE AMINOTRANSFERASE INCREASED |
344 |
0.0065 |
| 451 |
THROMBOTIC MICROANGIOPATHY |
63 |
0.0065 |
| 452 |
MITRAL VALVE INCOMPETENCE |
73 |
0.0064 |
| 453 |
LEUKOENCEPHALOPATHY |
24 |
0.0064 |
| 454 |
EJECTION FRACTION DECREASED |
100 |
0.0064 |
| 455 |
INFUSION SITE EXTRAVASATION |
40 |
0.0064 |
| 456 |
HYDROCEPHALUS |
35 |
0.0064 |
| 457 |
ANGIOPATHY |
36 |
0.0064 |
| 458 |
SUBARACHNOID HAEMORRHAGE |
65 |
0.0064 |
| 459 |
DUODENAL ULCER |
45 |
0.0064 |
| 460 |
HYPERLIPIDAEMIA |
76 |
0.0064 |
| 461 |
TOXIC SKIN ERUPTION |
64 |
0.0063 |
| 462 |
TRANSAMINASES INCREASED |
141 |
0.0063 |
| 463 |
HEART RATE DECREASED |
219 |
0.0062 |
| 464 |
MATERNAL EXPOSURE DURING PREGNANCY |
543 |
0.0061 |
| 465 |
ISCHAEMIA |
28 |
0.0061 |
| 466 |
HYPOPHOSPHATAEMIA |
45 |
0.0061 |
| 467 |
HYPERAESTHESIA |
50 |
0.0061 |
| 468 |
BREATH SOUNDS ABNORMAL |
30 |
0.0061 |
| 469 |
BACTERAEMIA |
72 |
0.0061 |
| 470 |
SPINAL OSTEOARTHRITIS |
53 |
0.0060 |
| 471 |
CHROMATURIA |
136 |
0.0060 |
| 472 |
CEREBRAL ATROPHY |
24 |
0.0060 |
| 473 |
AZOTAEMIA |
24 |
0.0060 |
| 474 |
IRON DEFICIENCY |
27 |
0.0060 |
| 475 |
ENTEROCOCCAL INFECTION |
29 |
0.0060 |
| 476 |
EXPOSURE DURING PREGNANCY |
373 |
0.0060 |
| 477 |
ARRHYTHMIA |
284 |
0.0060 |
| 478 |
MENTAL STATUS CHANGES |
166 |
0.0060 |
| 479 |
CARDIOMYOPATHY |
88 |
0.0059 |
| 480 |
BLOOD MAGNESIUM DECREASED |
51 |
0.0059 |
| 481 |
AMMONIA INCREASED |
30 |
0.0059 |
| 482 |
NEUROTOXICITY |
102 |
0.0058 |
| 483 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
24 |
0.0058 |
| 484 |
SCREAMING |
37 |
0.0058 |
| 485 |
DERMATITIS EXFOLIATIVE |
29 |
0.0058 |
| 486 |
GUILLAIN-BARRE SYNDROME |
28 |
0.0058 |
| 487 |
PNEUMONIA BACTERIAL |
53 |
0.0058 |
| 488 |
NEUROLOGICAL SYMPTOM |
33 |
0.0058 |
| 489 |
WRONG PRODUCT ADMINISTERED |
39 |
0.0058 |
| 490 |
PULMONARY CONGESTION |
76 |
0.0058 |
| 491 |
FOETAL GROWTH RESTRICTION |
35 |
0.0058 |
| 492 |
HEPATOTOXICITY |
128 |
0.0057 |
| 493 |
CREATININE RENAL CLEARANCE DECREASED |
23 |
0.0057 |
| 494 |
MALABSORPTION |
30 |
0.0057 |
| 495 |
ARTERIOSCLEROSIS CORONARY ARTERY |
38 |
0.0057 |
| 496 |
MIOSIS |
46 |
0.0057 |
| 497 |
JAUNDICE |
154 |
0.0057 |
| 498 |
RIGHT VENTRICULAR FAILURE |
40 |
0.0057 |
| 499 |
CARDIAC TAMPONADE |
27 |
0.0057 |
| 500 |
DRUG-INDUCED LIVER INJURY |
177 |
0.0056 |
| 501 |
AORTIC VALVE INCOMPETENCE |
24 |
0.0056 |
| 502 |
DIALYSIS |
79 |
0.0056 |
| 503 |
DRUG LEVEL INCREASED |
92 |
0.0056 |
| 504 |
BLOOD TRIGLYCERIDES INCREASED |
98 |
0.0055 |
| 505 |
ATRIAL FLUTTER |
44 |
0.0055 |
| 506 |
RESPIRATION ABNORMAL |
38 |
0.0055 |
| 507 |
HEPATIC ENCEPHALOPATHY |
50 |
0.0054 |
| 508 |
PERFORMANCE STATUS DECREASED |
25 |
0.0054 |
| 509 |
SEPSIS |
596 |
0.0053 |
| 510 |
ATAXIA |
63 |
0.0053 |
| 511 |
HYPOKALAEMIA |
245 |
0.0053 |
| 512 |
LIVER INJURY |
129 |
0.0053 |
| 513 |
CONVULSION |
297 |
0.0052 |
| 514 |
COLITIS ISCHAEMIC |
35 |
0.0052 |
| 515 |
TOXICITY TO VARIOUS AGENTS |
872 |
0.0052 |
| 516 |
RESPIRATORY DISORDER |
154 |
0.0051 |
| 517 |
ADRENAL INSUFFICIENCY |
62 |
0.0051 |
| 518 |
EPILEPSY |
156 |
0.0051 |
| 519 |
ELECTROLYTE IMBALANCE |
59 |
0.0051 |
| 520 |
RENAL FAILURE CHRONIC |
39 |
0.0051 |
| 521 |
STAPHYLOCOCCAL SEPSIS |
25 |
0.0051 |
| 522 |
ATRIAL FIBRILLATION |
490 |
0.0050 |
| 523 |
HYPOMAGNESAEMIA |
69 |
0.0050 |
| 524 |
CHOLECYSTITIS ACUTE |
28 |
0.0049 |
| 525 |
CLOSTRIDIUM DIFFICILE COLITIS |
52 |
0.0049 |
| 526 |
EYELID OEDEMA |
57 |
0.0049 |
| 527 |
ENDOCARDITIS |
25 |
0.0049 |
| 528 |
LIPASE INCREASED |
37 |
0.0048 |
| 529 |
MATERNAL DRUGS AFFECTING FOETUS |
37 |
0.0048 |
| 530 |
HEMIPLEGIA |
40 |
0.0048 |
| 531 |
PULMONARY HYPERTENSION |
100 |
0.0048 |
| 532 |
POOR QUALITY DRUG ADMINISTERED |
31 |
0.0048 |
| 533 |
HEPATIC FUNCTION ABNORMAL |
178 |
0.0048 |
| 534 |
CARDIOVASCULAR DISORDER |
121 |
0.0048 |
| 535 |
POISONING DELIBERATE |
45 |
0.0047 |
| 536 |
HAEMATEMESIS |
120 |
0.0047 |
| 537 |
INTESTINAL PERFORATION |
53 |
0.0047 |
| 538 |
CONCOMITANT DISEASE AGGRAVATED |
29 |
0.0047 |
| 539 |
GENERALISED OEDEMA |
58 |
0.0047 |
| 540 |
HEPATOMEGALY |
46 |
0.0047 |
| 541 |
DECUBITUS ULCER |
38 |
0.0047 |
| 542 |
HAEMOLYSIS |
36 |
0.0047 |
| 543 |
BLOOD UREA INCREASED |
78 |
0.0047 |
| 544 |
SEDATION |
122 |
0.0047 |
| 545 |
DRUG EXPOSURE DURING PREGNANCY |
158 |
0.0046 |
| 546 |
ANAL ABSCESS |
25 |
0.0046 |
| 547 |
MUSCLE TWITCHING |
106 |
0.0046 |
| 548 |
SEIZURE |
530 |
0.0046 |
| 549 |
ACUTE CORONARY SYNDROME |
38 |
0.0046 |
| 550 |
ABORTION INDUCED |
43 |
0.0046 |
| 551 |
ASCITES |
133 |
0.0045 |
| 552 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
111 |
0.0045 |
| 553 |
MYOCARDITIS |
51 |
0.0044 |
| 554 |
THROMBOCYTOPENIA |
495 |
0.0044 |
| 555 |
MYOPATHY |
38 |
0.0044 |
| 556 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
45 |
0.0044 |
| 557 |
EMPHYSEMA |
44 |
0.0044 |
| 558 |
AGRANULOCYTOSIS |
81 |
0.0044 |
| 559 |
PLEURAL EFFUSION |
265 |
0.0044 |
| 560 |
MEDICATION ERROR |
241 |
0.0043 |
| 561 |
LIVE BIRTH |
36 |
0.0043 |
| 562 |
CEREBRAL INFARCTION |
105 |
0.0043 |
| 563 |
DRUG RESISTANCE |
110 |
0.0043 |
| 564 |
POLYP |
28 |
0.0043 |
| 565 |
FLUID OVERLOAD |
62 |
0.0043 |
| 566 |
ESCHERICHIA INFECTION |
35 |
0.0043 |
| 567 |
REBOUND EFFECT |
48 |
0.0042 |
| 568 |
PERIORBITAL SWELLING |
24 |
0.0042 |
| 569 |
BLOOD CREATININE INCREASED |
277 |
0.0042 |
| 570 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
94 |
0.0042 |
| 571 |
HAEMOPTYSIS |
118 |
0.0042 |
| 572 |
PALLOR |
115 |
0.0042 |
| 573 |
APHASIA |
127 |
0.0042 |
| 574 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
37 |
0.0042 |
| 575 |
LARGE INTESTINE PERFORATION |
29 |
0.0042 |
| 576 |
HYPERGLYCAEMIA |
152 |
0.0042 |
| 577 |
ENTEROCOLITIS |
24 |
0.0042 |
| 578 |
ACUTE MYOCARDIAL INFARCTION |
122 |
0.0041 |
| 579 |
RASH PUSTULAR |
30 |
0.0041 |
| 580 |
EMOTIONAL DISTRESS |
498 |
0.0041 |
| 581 |
MALNUTRITION |
46 |
0.0041 |
| 582 |
LIVER FUNCTION TEST ABNORMAL |
119 |
0.0041 |
| 583 |
DISORIENTATION |
162 |
0.0041 |
| 584 |
END STAGE RENAL DISEASE |
74 |
0.0041 |
| 585 |
POST-TRAUMATIC STRESS DISORDER |
27 |
0.0040 |
| 586 |
HAEMOLYTIC ANAEMIA |
36 |
0.0040 |
| 587 |
INCOHERENT |
26 |
0.0040 |
| 588 |
BRONCHOPULMONARY ASPERGILLOSIS |
31 |
0.0040 |
| 589 |
ERYTHEMA MULTIFORME |
37 |
0.0040 |
| 590 |
CEREBRAL HAEMORRHAGE |
139 |
0.0039 |
| 591 |
CHILLS |
455 |
0.0039 |
| 592 |
LIVER FUNCTION TEST INCREASED |
82 |
0.0038 |
| 593 |
ULCER |
60 |
0.0038 |
| 594 |
TUBULOINTERSTITIAL NEPHRITIS |
70 |
0.0037 |
| 595 |
HYPOCALCAEMIA |
70 |
0.0037 |
| 596 |
INTERVERTEBRAL DISC DEGENERATION |
34 |
0.0037 |
| 597 |
POISONING |
46 |
0.0037 |
| 598 |
BLINDNESS TRANSIENT |
27 |
0.0037 |
| 599 |
DERMATITIS ALLERGIC |
46 |
0.0037 |
| 600 |
OROPHARYNGEAL DISCOMFORT |
33 |
0.0036 |
| 601 |
HIATUS HERNIA |
47 |
0.0036 |
| 602 |
HYPERCHOLESTEROLAEMIA |
35 |
0.0036 |
| 603 |
HAEMATURIA |
124 |
0.0036 |
| 604 |
RESTLESSNESS |
132 |
0.0036 |
| 605 |
SENSORY LOSS |
29 |
0.0036 |
| 606 |
CARDIAC FAILURE |
287 |
0.0036 |
| 607 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
61 |
0.0036 |
| 608 |
PSYCHOMOTOR HYPERACTIVITY |
59 |
0.0036 |
| 609 |
TUMOUR LYSIS SYNDROME |
31 |
0.0035 |
| 610 |
DIVERTICULUM |
25 |
0.0035 |
| 611 |
ARTERIOSCLEROSIS |
33 |
0.0035 |
| 612 |
DRUG ERUPTION |
62 |
0.0035 |
| 613 |
HEPATIC STEATOSIS |
65 |
0.0035 |
| 614 |
HEMIPARESIS |
59 |
0.0035 |
| 615 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
26 |
0.0035 |
| 616 |
EXTRAPYRAMIDAL DISORDER |
86 |
0.0035 |
| 617 |
ANAL INCONTINENCE |
31 |
0.0034 |
| 618 |
NERVOUS SYSTEM DISORDER |
107 |
0.0034 |
| 619 |
HEART RATE INCREASED |
338 |
0.0034 |
| 620 |
CEREBRAL DISORDER |
25 |
0.0034 |
| 621 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
24 |
0.0033 |
| 622 |
ABSCESS |
53 |
0.0033 |
| 623 |
THERAPY NON-RESPONDER |
149 |
0.0033 |
| 624 |
PANCREATITIS |
175 |
0.0033 |
| 625 |
WHEEZING |
196 |
0.0033 |
| 626 |
HICCUPS |
27 |
0.0033 |
| 627 |
QUALITY OF LIFE DECREASED |
44 |
0.0033 |
| 628 |
RENAL CYST |
26 |
0.0033 |
| 629 |
BLOOD PRESSURE DIASTOLIC DECREASED |
24 |
0.0032 |
| 630 |
RASH ERYTHEMATOUS |
155 |
0.0032 |
| 631 |
PYREXIA |
1116 |
0.0032 |
| 632 |
URTICARIA |
538 |
0.0032 |
| 633 |
HAEMATOMA |
83 |
0.0032 |
| 634 |
CYTOKINE RELEASE SYNDROME |
64 |
0.0032 |
| 635 |
SWOLLEN TONGUE |
99 |
0.0032 |
| 636 |
LOSS OF CONSCIOUSNESS |
406 |
0.0032 |
| 637 |
RASH GENERALISED |
81 |
0.0031 |
| 638 |
BLOOD PRESSURE SYSTOLIC INCREASED |
61 |
0.0031 |
| 639 |
DRUG ABUSE |
259 |
0.0031 |
| 640 |
HYPERTENSION |
659 |
0.0031 |
| 641 |
HYPOKINESIA |
45 |
0.0031 |
| 642 |
MYASTHENIA GRAVIS |
25 |
0.0031 |
| 643 |
MUSCLE SPASTICITY |
38 |
0.0031 |
| 644 |
HAEMATOCRIT DECREASED |
61 |
0.0031 |
| 645 |
ERYTHEMA |
630 |
0.0031 |
| 646 |
LYMPHOPENIA |
43 |
0.0030 |
| 647 |
WRONG DRUG ADMINISTERED |
27 |
0.0030 |
| 648 |
DYSARTHRIA |
114 |
0.0030 |
| 649 |
COGNITIVE DISORDER |
141 |
0.0030 |
| 650 |
AGGRESSION |
151 |
0.0030 |
| 651 |
ACCIDENTAL OVERDOSE |
110 |
0.0030 |
| 652 |
WHITE BLOOD CELL COUNT INCREASED |
115 |
0.0030 |
| 653 |
BLOOD DISORDER |
24 |
0.0030 |
| 654 |
PROCEDURAL PAIN |
83 |
0.0030 |
| 655 |
DISABILITY |
58 |
0.0029 |
| 656 |
POLYNEUROPATHY |
35 |
0.0029 |
| 657 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
49 |
0.0029 |
| 658 |
LIVER DISORDER |
129 |
0.0029 |
| 659 |
URINARY RETENTION |
97 |
0.0029 |
| 660 |
INTENTIONAL OVERDOSE |
186 |
0.0029 |
| 661 |
NEPHROPATHY TOXIC |
32 |
0.0028 |
| 662 |
SKIN LACERATION |
31 |
0.0028 |
| 663 |
STAPHYLOCOCCAL INFECTION |
94 |
0.0028 |
| 664 |
INCONTINENCE |
30 |
0.0028 |
| 665 |
UROSEPSIS |
26 |
0.0028 |
| 666 |
AKATHISIA |
38 |
0.0028 |
| 667 |
NEPHROPATHY |
26 |
0.0028 |
| 668 |
C-REACTIVE PROTEIN INCREASED |
101 |
0.0028 |
| 669 |
PARKINSONISM |
27 |
0.0028 |
| 670 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
124 |
0.0028 |
| 671 |
URINARY INCONTINENCE |
82 |
0.0028 |
| 672 |
OVERDOSE |
597 |
0.0028 |
| 673 |
COMPLETED SUICIDE |
230 |
0.0028 |
| 674 |
DEEP VEIN THROMBOSIS |
179 |
0.0028 |
| 675 |
ISCHAEMIC STROKE |
49 |
0.0027 |
| 676 |
HAEMORRHAGE INTRACRANIAL |
41 |
0.0027 |
| 677 |
HAEMORRHAGE |
283 |
0.0027 |
| 678 |
DRUG EFFECT DECREASED |
145 |
0.0027 |
| 679 |
CHOLECYSTITIS |
32 |
0.0027 |
| 680 |
MUSCLE ATROPHY |
34 |
0.0027 |
| 681 |
PRODUCT USE IN UNAPPROVED INDICATION |
664 |
0.0027 |
| 682 |
HYPERCALCAEMIA |
33 |
0.0027 |
| 683 |
INTERNATIONAL NORMALISED RATIO INCREASED |
76 |
0.0027 |
| 684 |
OEDEMA |
144 |
0.0027 |
| 685 |
ANXIETY |
754 |
0.0026 |
| 686 |
CONTRAINDICATED PRODUCT ADMINISTERED |
80 |
0.0026 |
| 687 |
SECRETION DISCHARGE |
33 |
0.0026 |
| 688 |
MOVEMENT DISORDER |
84 |
0.0026 |
| 689 |
NERVE INJURY |
29 |
0.0026 |
| 690 |
HEPATIC CIRRHOSIS |
49 |
0.0026 |
| 691 |
SUICIDE ATTEMPT |
158 |
0.0026 |
| 692 |
GASTROINTESTINAL HAEMORRHAGE |
215 |
0.0026 |
| 693 |
SPLENOMEGALY |
30 |
0.0026 |
| 694 |
PULMONARY EMBOLISM |
243 |
0.0026 |
| 695 |
WOUND INFECTION |
28 |
0.0026 |
| 696 |
PERICARDIAL EFFUSION |
59 |
0.0025 |
| 697 |
HYPONATRAEMIA |
143 |
0.0025 |
| 698 |
CONFUSIONAL STATE |
408 |
0.0025 |
| 699 |
SUBDURAL HAEMATOMA |
36 |
0.0025 |
| 700 |
HAEMORRHOIDS |
49 |
0.0025 |
| 701 |
ADVERSE REACTION |
33 |
0.0025 |
| 702 |
DRUG INEFFECTIVE |
3257 |
0.0025 |
| 703 |
SLEEP APNOEA SYNDROME |
47 |
0.0025 |
| 704 |
DRUG LEVEL DECREASED |
25 |
0.0025 |
| 705 |
GLOMERULAR FILTRATION RATE DECREASED |
30 |
0.0024 |
| 706 |
LIP SWELLING |
81 |
0.0024 |
| 707 |
PETECHIAE |
25 |
0.0024 |
| 708 |
CORONARY ARTERY DISEASE |
72 |
0.0024 |
| 709 |
SOMNOLENCE |
478 |
0.0024 |
| 710 |
JOINT DISLOCATION |
25 |
0.0024 |
| 711 |
NEUTROPHIL COUNT INCREASED |
24 |
0.0023 |
| 712 |
BODY TEMPERATURE DECREASED |
23 |
0.0023 |
| 713 |
BLOOD PRESSURE FLUCTUATION |
55 |
0.0023 |
| 714 |
HEPATIC ENZYME INCREASED |
154 |
0.0023 |
| 715 |
CONDITION AGGRAVATED |
686 |
0.0023 |
| 716 |
DIPLOPIA |
58 |
0.0022 |
| 717 |
PANCYTOPENIA |
124 |
0.0022 |
| 718 |
HYPERTHYROIDISM |
32 |
0.0022 |
| 719 |
OFF LABEL USE |
1921 |
0.0022 |
| 720 |
HAEMOGLOBIN DECREASED |
225 |
0.0022 |
| 721 |
SOPOR |
29 |
0.0022 |
| 722 |
CHRONIC KIDNEY DISEASE |
166 |
0.0022 |
| 723 |
HYPOGLYCAEMIA |
105 |
0.0022 |
| 724 |
MENTAL IMPAIRMENT |
52 |
0.0021 |
| 725 |
DEVICE RELATED INFECTION |
33 |
0.0021 |
| 726 |
PSYCHOTIC DISORDER |
63 |
0.0021 |
| 727 |
WITHDRAWAL SYNDROME |
89 |
0.0021 |
| 728 |
LEUKOPENIA |
106 |
0.0021 |
| 729 |
GENERAL PHYSICAL HEALTH DETERIORATION |
243 |
0.0021 |
| 730 |
CYST |
26 |
0.0021 |
| 731 |
DYSPHAGIA |
198 |
0.0021 |
| 732 |
DRUG ADMINISTRATION ERROR |
64 |
0.0021 |
| 733 |
SPEECH DISORDER |
108 |
0.0021 |
| 734 |
OSTEOARTHRITIS |
87 |
0.0021 |
| 735 |
GASTRIC ULCER |
39 |
0.0020 |
| 736 |
MUSCULAR WEAKNESS |
233 |
0.0020 |
| 737 |
PNEUMONIA |
663 |
0.0020 |
| 738 |
INTERSTITIAL LUNG DISEASE |
99 |
0.0020 |
| 739 |
HYPERSENSITIVITY |
377 |
0.0020 |
| 740 |
PHARYNGEAL OEDEMA |
31 |
0.0020 |
| 741 |
CHOLELITHIASIS |
66 |
0.0020 |
| 742 |
ANAEMIA |
381 |
0.0020 |
| 743 |
HYPERHIDROSIS |
256 |
0.0020 |
| 744 |
MELAENA |
43 |
0.0020 |
| 745 |
TREATMENT FAILURE |
161 |
0.0019 |
| 746 |
BLOOD PRESSURE INCREASED |
297 |
0.0019 |
| 747 |
BLOOD POTASSIUM DECREASED |
58 |
0.0019 |
| 748 |
ECONOMIC PROBLEM |
29 |
0.0019 |
| 749 |
MANIA |
31 |
0.0019 |
| 750 |
PERITONITIS |
39 |
0.0019 |
| 751 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
68 |
0.0019 |
| 752 |
LYMPHOCYTE COUNT DECREASED |
33 |
0.0019 |
| 753 |
HALLUCINATION, VISUAL |
39 |
0.0018 |
| 754 |
SKIN REACTION |
26 |
0.0018 |
| 755 |
PROTEINURIA |
35 |
0.0018 |
| 756 |
PLATELET COUNT INCREASED |
24 |
0.0018 |
| 757 |
RETCHING |
39 |
0.0018 |
| 758 |
BACTERIAL INFECTION |
34 |
0.0018 |
| 759 |
SENSORY DISTURBANCE |
29 |
0.0018 |
| 760 |
ABDOMINAL DISTENSION |
188 |
0.0018 |
| 761 |
DRUG WITHDRAWAL SYNDROME |
157 |
0.0018 |
| 762 |
HYPOTHYROIDISM |
57 |
0.0018 |
| 763 |
PLATELET COUNT DECREASED |
189 |
0.0018 |
| 764 |
AMNESIA |
115 |
0.0018 |
| 765 |
IMPAIRED GASTRIC EMPTYING |
24 |
0.0018 |
| 766 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
26 |
0.0018 |
| 767 |
GASTRITIS |
46 |
0.0017 |
| 768 |
RASH |
762 |
0.0017 |
| 769 |
MUSCLE TIGHTNESS |
28 |
0.0017 |
| 770 |
PNEUMONITIS |
47 |
0.0017 |
| 771 |
COORDINATION ABNORMAL |
24 |
0.0017 |
| 772 |
FLUSHING |
174 |
0.0017 |
| 773 |
PRESCRIBED OVERDOSE |
33 |
0.0017 |
| 774 |
VOMITING |
797 |
0.0017 |
| 775 |
LETHARGY |
97 |
0.0017 |
| 776 |
PRODUCT ADMINISTRATION ERROR |
34 |
0.0017 |
| 777 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
60 |
0.0017 |
| 778 |
LUNG DISORDER |
82 |
0.0017 |
| 779 |
CELLULITIS |
84 |
0.0017 |
| 780 |
DIVERTICULITIS |
46 |
0.0017 |
| 781 |
FEBRILE NEUTROPENIA |
110 |
0.0017 |
| 782 |
PULMONARY ARTERIAL HYPERTENSION |
24 |
0.0017 |
| 783 |
RASH PAPULAR |
37 |
0.0016 |
| 784 |
OSTEOPENIA |
25 |
0.0016 |
| 785 |
PAIN |
1006 |
0.0016 |
| 786 |
SWELLING FACE |
106 |
0.0016 |
| 787 |
TREMOR |
269 |
0.0016 |
| 788 |
DRUG EFFECT LESS THAN EXPECTED |
24 |
0.0016 |
| 789 |
CONJUNCTIVITIS |
30 |
0.0016 |
| 790 |
LUNG INFECTION |
25 |
0.0016 |
| 791 |
INFLAMMATION |
83 |
0.0016 |
| 792 |
CLOSTRIDIUM DIFFICILE INFECTION |
35 |
0.0016 |
| 793 |
RASH MACULAR |
56 |
0.0016 |
| 794 |
CARDIAC FAILURE CONGESTIVE |
124 |
0.0015 |
| 795 |
RESTLESS LEGS SYNDROME |
28 |
0.0015 |
| 796 |
SNEEZING |
34 |
0.0015 |
| 797 |
DEVICE FAILURE |
23 |
0.0015 |
| 798 |
IMPAIRED WORK ABILITY |
32 |
0.0015 |
| 799 |
SCAR |
25 |
0.0015 |
| 800 |
MENTAL DISORDER |
63 |
0.0014 |
| 801 |
HALLUCINATION |
109 |
0.0014 |
| 802 |
TREATMENT NONCOMPLIANCE |
79 |
0.0014 |
| 803 |
OSTEOMYELITIS |
26 |
0.0014 |
| 804 |
BONE MARROW FAILURE |
29 |
0.0014 |
| 805 |
DEPRESSION |
324 |
0.0014 |
| 806 |
PRODUCT QUALITY ISSUE |
192 |
0.0014 |
| 807 |
MOOD SWINGS |
45 |
0.0014 |
| 808 |
DYSPNOEA |
794 |
0.0014 |
| 809 |
COLITIS |
53 |
0.0014 |
| 810 |
EPISTAXIS |
104 |
0.0014 |
| 811 |
PHARMACEUTICAL PRODUCT COMPLAINT |
36 |
0.0014 |
| 812 |
OSTEONECROSIS OF JAW |
34 |
0.0014 |
| 813 |
BLISTER |
77 |
0.0014 |
| 814 |
INTENTIONAL PRODUCT MISUSE |
120 |
0.0014 |
| 815 |
CEREBROVASCULAR ACCIDENT |
232 |
0.0014 |
| 816 |
GASTROOESOPHAGEAL REFLUX DISEASE |
110 |
0.0014 |
| 817 |
MYOCARDIAL INFARCTION |
237 |
0.0014 |
| 818 |
LYMPHADENOPATHY |
48 |
0.0014 |
| 819 |
DYSURIA |
49 |
0.0013 |
| 820 |
OEDEMA PERIPHERAL |
162 |
0.0013 |
| 821 |
FEELING COLD |
37 |
0.0013 |
| 822 |
HEART RATE IRREGULAR |
30 |
0.0013 |
| 823 |
DYSPNOEA EXERTIONAL |
50 |
0.0013 |
| 824 |
BONE DISORDER |
24 |
0.0013 |
| 825 |
ABNORMAL BEHAVIOUR |
52 |
0.0013 |
| 826 |
COUGH |
366 |
0.0013 |
| 827 |
COLD SWEAT |
23 |
0.0013 |
| 828 |
BLOOD SODIUM DECREASED |
24 |
0.0013 |
| 829 |
NEUTROPENIA |
173 |
0.0013 |
| 830 |
SYNCOPE |
127 |
0.0013 |
| 831 |
FUNGAL INFECTION |
42 |
0.0013 |
| 832 |
BLOOD PRESSURE ABNORMAL |
25 |
0.0013 |
| 833 |
ABDOMINAL PAIN |
291 |
0.0012 |
| 834 |
THERAPEUTIC RESPONSE DECREASED |
75 |
0.0012 |
| 835 |
RED BLOOD CELL COUNT DECREASED |
35 |
0.0012 |
| 836 |
INFECTION |
177 |
0.0012 |
| 837 |
PAIN IN JAW |
34 |
0.0012 |
| 838 |
TINNITUS |
55 |
0.0012 |
| 839 |
LIMB DISCOMFORT |
37 |
0.0012 |
| 840 |
RECTAL HAEMORRHAGE |
51 |
0.0012 |
| 841 |
DEAFNESS |
31 |
0.0012 |
| 842 |
DEHYDRATION |
157 |
0.0012 |
| 843 |
CARDIAC DISORDER |
110 |
0.0012 |
| 844 |
SKIN ULCER |
30 |
0.0012 |
| 845 |
THROMBOSIS |
93 |
0.0012 |
| 846 |
MYALGIA |
194 |
0.0011 |
| 847 |
RENAL DISORDER |
53 |
0.0011 |
| 848 |
FLATULENCE |
64 |
0.0011 |
| 849 |
FAECES DISCOLOURED |
24 |
0.0011 |
| 850 |
IRRITABILITY |
66 |
0.0011 |
| 851 |
TRANSIENT ISCHAEMIC ATTACK |
37 |
0.0011 |
| 852 |
INTENTIONAL PRODUCT USE ISSUE |
96 |
0.0011 |
| 853 |
DISTURBANCE IN ATTENTION |
59 |
0.0011 |
| 854 |
CHEST PAIN |
201 |
0.0011 |
| 855 |
BACK PAIN |
247 |
0.0011 |
| 856 |
INTERVERTEBRAL DISC PROTRUSION |
23 |
0.0011 |
| 857 |
PRODUCT USE ISSUE |
197 |
0.0010 |
| 858 |
NAUSEA |
826 |
0.0010 |
| 859 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
74 |
0.0010 |
| 860 |
ASTHENIA |
391 |
0.0010 |
| 861 |
OROPHARYNGEAL PAIN |
96 |
0.0010 |
| 862 |
RASH PRURITIC |
56 |
0.0010 |
| 863 |
PRODUCTIVE COUGH |
49 |
0.0010 |
| 864 |
SKIN DISCOLOURATION |
47 |
0.0010 |
| 865 |
URINARY TRACT INFECTION |
171 |
0.0010 |
| 866 |
WOUND |
28 |
0.0010 |
| 867 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
29 |
0.0010 |
| 868 |
DISEASE RECURRENCE |
47 |
0.0010 |
| 869 |
PRESYNCOPE |
24 |
0.0010 |
| 870 |
SKIN LESION |
27 |
0.0010 |
| 871 |
HEAD INJURY |
31 |
0.0010 |
| 872 |
SLEEP DISORDER |
69 |
0.0010 |
| 873 |
ANGINA PECTORIS |
28 |
0.0010 |
| 874 |
IMPAIRED HEALING |
32 |
0.0010 |
| 875 |
EMOTIONAL DISORDER |
30 |
0.0010 |
| 876 |
MUSCULOSKELETAL STIFFNESS |
84 |
0.0010 |
| 877 |
DIABETES MELLITUS |
73 |
0.0010 |
| 878 |
DIABETIC KETOACIDOSIS |
23 |
0.0010 |
| 879 |
PARAESTHESIA |
150 |
0.0010 |
| 880 |
UPPER RESPIRATORY TRACT INFECTION |
44 |
0.0010 |
| 881 |
CHEST DISCOMFORT |
97 |
0.0009 |
| 882 |
NEUTROPHIL COUNT DECREASED |
38 |
0.0009 |
| 883 |
ASTHMA |
105 |
0.0009 |
| 884 |
NERVOUSNESS |
48 |
0.0009 |
| 885 |
HYPOAESTHESIA |
136 |
0.0009 |
| 886 |
DRUG EFFECT INCOMPLETE |
32 |
0.0009 |
| 887 |
PANIC ATTACK |
32 |
0.0009 |
| 888 |
DYSPHONIA |
51 |
0.0009 |
| 889 |
DISCOMFORT |
53 |
0.0009 |
| 890 |
NO ADVERSE EVENT |
157 |
0.0009 |
| 891 |
FEELING HOT |
53 |
0.0009 |
| 892 |
SWELLING |
80 |
0.0009 |
| 893 |
TARDIVE DYSKINESIA |
24 |
0.0008 |
| 894 |
DEATH |
732 |
0.0008 |
| 895 |
MOBILITY DECREASED |
60 |
0.0008 |
| 896 |
MEMORY IMPAIRMENT |
114 |
0.0008 |
| 897 |
INTESTINAL OBSTRUCTION |
31 |
0.0008 |
| 898 |
BLINDNESS |
33 |
0.0008 |
| 899 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
42 |
0.0008 |
| 900 |
MUSCLE SPASMS |
147 |
0.0008 |
| 901 |
GAIT DISTURBANCE |
153 |
0.0008 |
| 902 |
POLLAKIURIA |
33 |
0.0008 |
| 903 |
LABORATORY TEST ABNORMAL |
23 |
0.0008 |
| 904 |
CONSTIPATION |
169 |
0.0008 |
| 905 |
INFUSION RELATED REACTION |
50 |
0.0008 |
| 906 |
NECK PAIN |
42 |
0.0008 |
| 907 |
SURGERY |
44 |
0.0007 |
| 908 |
PRODUCT SUBSTITUTION ISSUE |
43 |
0.0007 |
| 909 |
CRYING |
27 |
0.0007 |
| 910 |
RHINORRHOEA |
48 |
0.0007 |
| 911 |
DISEASE PROGRESSION |
87 |
0.0007 |
| 912 |
ACCIDENTAL EXPOSURE TO PRODUCT |
75 |
0.0007 |
| 913 |
PALPITATIONS |
85 |
0.0007 |
| 914 |
HAEMATOCHEZIA |
40 |
0.0007 |
| 915 |
NIGHTMARE |
25 |
0.0007 |
| 916 |
SKIN DISORDER |
24 |
0.0007 |
| 917 |
NEPHROLITHIASIS |
33 |
0.0007 |
| 918 |
VAGINAL HAEMORRHAGE |
31 |
0.0007 |
| 919 |
INFLUENZA LIKE ILLNESS |
58 |
0.0007 |
| 920 |
WHITE BLOOD CELL COUNT DECREASED |
76 |
0.0007 |
| 921 |
PRURITUS |
267 |
0.0007 |
| 922 |
MUSCULOSKELETAL PAIN |
36 |
0.0007 |
| 923 |
WEIGHT DECREASED |
190 |
0.0007 |
| 924 |
VISION BLURRED |
91 |
0.0007 |
| 925 |
BURNING SENSATION |
46 |
0.0007 |
| 926 |
DIZZINESS |
325 |
0.0007 |
| 927 |
ILL-DEFINED DISORDER |
39 |
0.0006 |
| 928 |
MIGRAINE |
61 |
0.0006 |
| 929 |
LOWER RESPIRATORY TRACT INFECTION |
29 |
0.0006 |
| 930 |
VISUAL IMPAIRMENT |
79 |
0.0006 |
| 931 |
ABDOMINAL PAIN UPPER |
131 |
0.0006 |
| 932 |
FLUID RETENTION |
32 |
0.0006 |
| 933 |
BRONCHITIS |
46 |
0.0006 |
| 934 |
INSOMNIA |
163 |
0.0006 |
| 935 |
NEUROPATHY PERIPHERAL |
58 |
0.0006 |
| 936 |
DRUG DEPENDENCE |
98 |
0.0006 |
| 937 |
OSTEOPOROSIS |
25 |
0.0006 |
| 938 |
THROAT IRRITATION |
27 |
0.0006 |
| 939 |
BALANCE DISORDER |
52 |
0.0006 |
| 940 |
ROAD TRAFFIC ACCIDENT |
25 |
0.0006 |
| 941 |
HEADACHE |
371 |
0.0006 |
| 942 |
DEVICE ISSUE |
53 |
0.0006 |
| 943 |
ADVERSE DRUG REACTION |
53 |
0.0006 |
| 944 |
FALL |
194 |
0.0006 |
| 945 |
CATARACT |
34 |
0.0006 |
| 946 |
GASTROINTESTINAL DISORDER |
51 |
0.0006 |
| 947 |
EXTRA DOSE ADMINISTERED |
23 |
0.0006 |
| 948 |
DIARRHOEA |
364 |
0.0006 |
| 949 |
DRUG INTOLERANCE |
54 |
0.0006 |
| 950 |
VERTIGO |
34 |
0.0006 |
| 951 |
ARTHROPATHY |
31 |
0.0006 |
| 952 |
DYSPEPSIA |
54 |
0.0005 |
| 953 |
COVID-19 |
95 |
0.0005 |
| 954 |
DEVICE MALFUNCTION |
38 |
0.0005 |
| 955 |
DECREASED APPETITE |
125 |
0.0005 |
| 956 |
ECZEMA |
28 |
0.0005 |
| 957 |
MALAISE |
231 |
0.0005 |
| 958 |
PAIN IN EXTREMITY |
153 |
0.0005 |
| 959 |
THERAPY CESSATION |
26 |
0.0005 |
| 960 |
BLOOD GLUCOSE INCREASED |
95 |
0.0005 |
| 961 |
DRY MOUTH |
39 |
0.0005 |
| 962 |
STOMATITIS |
29 |
0.0005 |
| 963 |
SUICIDAL IDEATION |
43 |
0.0005 |
| 964 |
DRY EYE |
23 |
0.0005 |
| 965 |
INCORRECT DOSE ADMINISTERED |
104 |
0.0005 |
| 966 |
HERPES ZOSTER |
26 |
0.0005 |
| 967 |
SKIN EXFOLIATION |
38 |
0.0004 |
| 968 |
EYE PAIN |
25 |
0.0004 |
| 969 |
CONTUSION |
42 |
0.0004 |
| 970 |
ADVERSE EVENT |
39 |
0.0004 |
| 971 |
UNDERDOSE |
30 |
0.0004 |
| 972 |
INJECTION SITE SWELLING |
31 |
0.0004 |
| 973 |
DYSGEUSIA |
30 |
0.0004 |
| 974 |
PERIPHERAL SWELLING |
62 |
0.0004 |
| 975 |
FATIGUE |
305 |
0.0004 |
| 976 |
SINUSITIS |
40 |
0.0004 |
| 977 |
INFLUENZA |
42 |
0.0004 |
| 978 |
FEELING ABNORMAL |
85 |
0.0004 |
| 979 |
RHEUMATOID ARTHRITIS |
39 |
0.0003 |
| 980 |
ABDOMINAL DISCOMFORT |
57 |
0.0003 |
| 981 |
ARTHRALGIA |
140 |
0.0003 |
| 982 |
WEIGHT INCREASED |
75 |
0.0003 |
| 983 |
INJECTION SITE REACTION |
23 |
0.0003 |
| 984 |
MALIGNANT NEOPLASM PROGRESSION |
33 |
0.0003 |
| 985 |
ARTHRITIS |
25 |
0.0003 |
| 986 |
JOINT SWELLING |
27 |
0.0002 |
| 987 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
44 |
0.0002 |
| 988 |
NASOPHARYNGITIS |
39 |
0.0002 |
| 989 |
ALOPECIA |
39 |
0.0002 |
| 990 |
HOSPITALISATION |
27 |
0.0002 |
| 991 |
PRODUCT DOSE OMISSION ISSUE |
48 |
0.0002 |
| 992 |
INJECTION SITE PAIN |
48 |
0.0002 |
| 993 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
27 |
0.0001 |